Common Food Preservative Improves Schizophrenia Treatment
Summary: A randomized, double-blind, placebo-controlled trial found that sodium benzoate, a common food preservative and D-amino acid oxidase inhibitor, improved negative symptoms and overall outcomes for people with schizophrenia who remained symptomatic despite treatment with clozapine. Source: Elsevier The common preservative sodium benzoate improves symptoms in clozapine-resistant schizophrenia patients, according to a new clinical trial … Read more